Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada
Ocugen Inc., Bharat Biotech s partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing. The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, it said on Thursday.Â
Often referred to as a rolling review, this allows Health Canada to start its review right away, as information continues to come in, to accelerate the overall review process.
Ocugen initiated the rolling submission through its affiliate, Vaccigen, Ltd.
India reports 38,949 new COVID-19 cases, 542 deaths in last 24 hours
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
India s top research body scientist says Covid-19 third wave likely to hit by August end
thestar.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestar.com.my Daily Mail and Mail on Sunday newspapers.
Delta major variant responsible for breakthrough infections during second wave of COVID-19 in India
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Bharat Biotech s partner Ocugen seeks approval for Covaxin in Canada
dtnext.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtnext.in Daily Mail and Mail on Sunday newspapers.